Glypican 1 (GPC1) levels on pancreatic cancer-derived sEVs indicated cancer burden in patients before and after surgery, exhibiting significant diagnostic and predictive potentials (96, 109). The gene discussed is GPC1; the disease is pancreatic neoplasm.